Proveri Inc is categorized under Diagnostic Substances in San Diego, CA and active since 2004.
Proveri Inc was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Diagnostic Substances business, which does work in the B2B market, and is classified as a Diagnostic Substances, under code number 325412 by the NAICS.
If you are seeking more information, feel free to contact Waldemar Lernhardt Phd at the company’s single location by writing to 6195 Cornerstone Court East # 110, San Diego, California CA 92121 or by phoning (858) 736-6540. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Proveri Inc |
| Contact Person: | Waldemar Lernhardt Phd |
| Address: | 6195 Cornerstone Court East # 110, San Diego, California 92121 |
| Phone Number: | (858) 736-6540 |
| Website Address: | artyxpharma.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2004 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Diagnostic Substances |
| SIC Code: | 2835 |
| NAICS Code: | 325412 |
| Share This Business: |
Proveri Inc was started in 2004 to provide professional Diagnostic Substances under the SIC code 2835 and NAICS code 325412. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Waldemar Lernhardt Phd for inquiries that concern Proveri Inc by calling the company number (858) 736-6540, as your correspondence is most welcome. Additionally, the physical location of the single location of Proveri Inc can be found at the coordinates 32.895938,-117.18826 as well as the street address 6195 Cornerstone Court East # 110 in San Diego, California 92121.
For its online presence, you may visit Proveri Inc’s website at artyxpharma.com and engage with its social media outlets through on Twitter and on Facebook.